Factors associated with initiation of antihyperglycaemic medication in UK patients with newly diagnosed type 2 diabetes

被引：0
|
作者：
Alan J Sinclair
Charles M Alexander
Michael J Davies
Changgeng Zhao
Panagiotis Mavros
机构：
[1] Beds & Herts Postgraduate Medical School,
[2] Merck Sharp & Dohme Corp,undefined
[3] Global Health Outcomes,undefined
[4] Merck Sharp & Dohme Corp,undefined
来源：
BMC Endocrine Disorders | / 12卷
关键词：
Clinical inertia; Age; Type 2 diabetes mellitus; Antihyperglycaemic medication;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Factors associated with initiation of antihyperglycaemic medication in UK patients with newly diagnosed type 2 diabetes
    Sinclair, Alan J.
    Alexander, Charles M.
    Davies, Michael J.
    Zhao, Changgeng
    Mavros, Panagiotis
    BMC ENDOCRINE DISORDERS, 2012, 12
  • [2] Time to treatment initiation with oral antihyperglycaemic therapy in US patients with newly diagnosed type 2 diabetes
    Zhang, Q.
    Rajagopalan, S.
    Marrett, E.
    Davies, M. J.
    Radican, L.
    Engel, S. S.
    DIABETES OBESITY & METABOLISM, 2012, 14 (02): : 149 - 154
  • [3] TIME TO INITIATION OF ORAL ANTIHYPERGLYCAEMIC AND STATIN THERAPY IN PATIENTS WITH NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS
    Tunceli, K.
    Sun, P.
    Seck, T.
    Ambegaonkar, B.
    Lento, K.
    Davies, M. J.
    Zhang, Q.
    Radican, L.
    VALUE IN HEALTH, 2011, 14 (07) : A387 - A387
  • [4] Factors and Characteristics for Medication Initiation in Type 2 Diabetes Patients in the UK
    Wright, Alison K.
    Rutter, Martin K.
    Emsley, Richard
    Ashcroft, Darren M.
    Steinke, Douglas
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 70 - 71
  • [5] Factors associated with adherence to oral antihyperglycaemic monotherapy in patients with type 2 diabetes in the UK
    Tunceli, K.
    Zhao, C.
    Iglay, K.
    Brodovicz, K. G.
    Alexander, C. M.
    Radican, L.
    DIABETOLOGIA, 2014, 57 : S140 - S140
  • [6] Racial and Ethnic Differences in Medication Initiation Among Adults Newly Diagnosed with Type 2 Diabetes
    Gopalan, Anjali
    Winn, Aaron N.
    Karter, Andrew J.
    Laiteerapong, Neda
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2023, 38 (04) : 994 - 1000
  • [7] Racial and Ethnic Differences in Medication Initiation Among Adults Newly Diagnosed with Type 2 Diabetes
    Anjali Gopalan
    Aaron N. Winn
    Andrew J. Karter
    Neda Laiteerapong
    Journal of General Internal Medicine, 2023, 38 : 994 - 1000
  • [8] Antihyperglycaemic medication modifies factors of postprandial satiety in type 2 diabetes
    Mourad, C.
    Chevalier, S.
    Morais, J. A.
    Lamarche, M.
    Gougeon, R.
    DIABETES OBESITY & METABOLISM, 2009, 11 (08): : 819 - 822
  • [9] Diabetic retinopathy in patients with newly diagnosed type 2 diabetes mellitus in Jordan: Prevalence and associated factors
    Jammal, Hisham
    Khader, Yousef
    Alkhatib, Shadi
    Abujbara, Mousa
    Alomari, Mousa
    Ajlouni, Kamel
    JOURNAL OF DIABETES, 2013, 5 (02) : 172 - 179
  • [10] Older patients with newly diagnosed type 2 diabetes are less likely to be treated with oral antihyperglycaemic agents compared to younger patients
    Rajagopalan, S.
    Marrett, E.
    Radican, L.
    Zhang, Q.
    DIABETOLOGIA, 2009, 52 : S353 - S354
12345